News Category: Industry News

The pandemic has resulted in unprecedented levels of demand for device testing with requests for rapid turnaround times. Read More

In the risk management phase of medical device development, having as much information as possible about every input into the final product is critical – from raw materials and manufacturing […]

Changes in testing protocols and revised regulatory demands make testing experts even more valuable than they’ve ever been. Read More

We hope that this message finds you well. As the world moves into a variety of different reopening phases, we wanted to take a moment to reiterate our commitment to […]

During this ongoing COVID-19 pandemic, Toxikon has continued to work hard to serve industry as a single-source provider for preclinical safety and efficacy testing to ensure healthcare products can reach […]

We know now more than ever with the COVID-19 crisis that the essential services we provide our customers have never been more critical. Toxikon is working diligently to continue to […]

With the ongoing COVID-19 pandemic, we are continuing to update you on any changes or impacts at Toxikon relative to the services we provide our customers world-wide. Starting today, March […]

This roundtable discussion examines the technological and regulatory factors affecting the third-party testing and analysis services industry.

Toxikon Corporation, a leading global preclinical contract research organization (CRO), has launched a new website at www.toxikon.com, targeted towards scientists, engineers, and regulatory professionals involved in developing and commercializing medical […]

Toxikon is pleased to announce that effective 1 September 2018, we have reopened its European office in Almelo, The Netherlands, to better support our growing and existing European customers, which […]